<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Med Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Med Genet</journal-id>
      <journal-id journal-id-type="hwp">jmedgenet</journal-id>
      <journal-id journal-id-type="publisher-id">jmg</journal-id>
      <journal-title-group>
        <journal-title>Journal of Medical Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0022-2593</issn>
      <issn pub-type="epub">1468-6244</issn>
      <publisher>
        <publisher-name>BMJ Publishing Group</publisher-name>
        <publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34952832</article-id>
      <article-id pub-id-type="pmc">9554030</article-id>
      <article-id pub-id-type="publisher-id">jmedgenet-2021-108150</article-id>
      <article-id pub-id-type="doi">10.1136/jmedgenet-2021-108150</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Novel Disease Loci</subject>
        </subj-group>
        <subj-group subj-group-type="hwp-journal-coll">
          <subject>1506</subject>
        </subj-group>
        <series-title>Original research</series-title>
      </article-categories>
      <title-group>
        <article-title>A disorder clinically resembling cystic fibrosis caused by biallelic variants in the <italic toggle="yes">AGR2</italic> gene</article-title>
      </title-group>
      <contrib-group>
        <contrib id="author-64830504" contrib-type="author" corresp="yes" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9544-1877</contrib-id>
          <name>
            <surname>Bertoli-Avella</surname>
            <given-names>Aida</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-91061266" contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Hotakainen</surname>
            <given-names>Ronja</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-63285478" contrib-type="author">
          <name>
            <surname>Al Shehhi</surname>
            <given-names>Maryam</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib id="author-91054693" contrib-type="author">
          <name>
            <surname>Urzi</surname>
            <given-names>Alice</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-85104864" contrib-type="author">
          <name>
            <surname>Pareira</surname>
            <given-names>Catarina</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-67119979" contrib-type="author">
          <name>
            <surname>Marais</surname>
            <given-names>Anett</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-91054742" contrib-type="author">
          <name>
            <surname>Al Shidhani</surname>
            <given-names>Khoula</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib id="author-91054775" contrib-type="author">
          <name>
            <surname>Aloraimi</surname>
            <given-names>Sumaya</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib id="author-91054814" contrib-type="author">
          <name>
            <surname>Morales-Torres</surname>
            <given-names>Galina</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-91054822" contrib-type="author">
          <name>
            <surname>Fisher</surname>
            <given-names>Steffen</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-91054837" contrib-type="author">
          <name>
            <surname>Demuth</surname>
            <given-names>Laura</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-91054930" contrib-type="author">
          <name>
            <surname>Moteleb Selim</surname>
            <given-names>Laila Abdel</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib id="author-91054961" contrib-type="author">
          <name>
            <surname>Al Menabawy</surname>
            <given-names>Nihal</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib id="author-91054996" contrib-type="author">
          <name>
            <surname>Busehail</surname>
            <given-names>Maryam</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib id="author-91055015" contrib-type="author">
          <name>
            <surname>AlShaikh</surname>
            <given-names>Mohammed</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib id="author-91055054" contrib-type="author">
          <name>
            <surname>Gilani</surname>
            <given-names>Naser</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib id="author-91055101" contrib-type="author">
          <name>
            <surname>Chalabi</surname>
            <given-names>Dler Nooruldeen</given-names>
          </name>
          <xref rid="aff7" ref-type="aff">7</xref>
        </contrib>
        <contrib id="author-91055135" contrib-type="author">
          <name>
            <surname>Alharbi</surname>
            <given-names>Nasser S</given-names>
          </name>
          <xref rid="aff8" ref-type="aff">8</xref>
        </contrib>
        <contrib id="author-68114999" contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9427-7240</contrib-id>
          <name>
            <surname>Alfadhel</surname>
            <given-names>Majid</given-names>
          </name>
          <xref rid="aff9" ref-type="aff">9</xref>
          <xref rid="aff10" ref-type="aff">10</xref>
        </contrib>
        <contrib id="author-91061197" contrib-type="author">
          <name>
            <surname>Abdelrahman</surname>
            <given-names>Mohammed</given-names>
          </name>
          <xref rid="aff11" ref-type="aff">11</xref>
        </contrib>
        <contrib id="author-36015301" contrib-type="author">
          <name>
            <surname>Venselaar</surname>
            <given-names>Hanka</given-names>
          </name>
          <xref rid="aff12" ref-type="aff">12</xref>
        </contrib>
        <contrib id="author-91055250" contrib-type="author">
          <name>
            <surname>Anjum</surname>
            <given-names>Nadeem</given-names>
          </name>
          <xref rid="aff13" ref-type="aff">13</xref>
        </contrib>
        <contrib id="author-91055297" contrib-type="author">
          <name>
            <surname>Saeed</surname>
            <given-names>Anjum</given-names>
          </name>
          <xref rid="aff13" ref-type="aff">13</xref>
        </contrib>
        <contrib id="author-91055325" contrib-type="author">
          <name>
            <surname>Alghamdi</surname>
            <given-names>Malak Ali</given-names>
          </name>
          <xref rid="aff14" ref-type="aff">14</xref>
        </contrib>
        <contrib id="author-91055378" contrib-type="author">
          <name>
            <surname>Aljaedi</surname>
            <given-names>Hamad</given-names>
          </name>
          <xref rid="aff15" ref-type="aff">15</xref>
        </contrib>
        <contrib id="author-93354240" contrib-type="author">
          <name>
            <surname>Arabi</surname>
            <given-names>Hisham</given-names>
          </name>
          <xref rid="aff16" ref-type="aff">16</xref>
        </contrib>
        <contrib id="author-66899693" contrib-type="author">
          <name>
            <surname>Karageorgou</surname>
            <given-names>Vasiliki</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-91055408" contrib-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>Suliman</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-91055439" contrib-type="author">
          <name>
            <surname>Hajjari</surname>
            <given-names>Zahra</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-91055457" contrib-type="author">
          <name>
            <surname>Radefeldt</surname>
            <given-names>Mandy</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-91055477" contrib-type="author">
          <name>
            <surname>Al-Ali</surname>
            <given-names>Ruslan</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-91055504" contrib-type="author">
          <name>
            <surname>Tripolszki</surname>
            <given-names>Kornelia</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-91055537" contrib-type="author">
          <name>
            <surname>Jamhawi</surname>
            <given-names>Amer</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-67120102" contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1173-5363</contrib-id>
          <name>
            <surname>Paknia</surname>
            <given-names>Omid</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-68580815" contrib-type="author">
          <name>
            <surname>Cozma</surname>
            <given-names>Claudia</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-91055588" contrib-type="author">
          <name>
            <surname>Cheema</surname>
            <given-names>Huma</given-names>
          </name>
          <xref rid="aff13" ref-type="aff">13</xref>
        </contrib>
        <contrib id="author-69769026" contrib-type="author">
          <name>
            <surname>Ameziane</surname>
            <given-names>Najim</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib id="author-91055626" contrib-type="author">
          <name>
            <surname>Al-Muhsen</surname>
            <given-names>Saleh</given-names>
          </name>
          <xref rid="aff11" ref-type="aff">11</xref>
        </contrib>
        <contrib id="author-54584197" contrib-type="author">
          <name>
            <surname>Bauer</surname>
            <given-names>Peter</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
<label>1</label>
<institution content-type="department">Medical Reporting &amp; Genomic Research</institution>, <institution>Centogene GmbH</institution>, <addr-line content-type="city">Rostock</addr-line>, <country>Germany</country>
</aff>
      <aff id="aff2">
<label>2</label>
<institution content-type="department">Child Health Department</institution>, <institution>The Royal Hospital</institution>, <addr-line content-type="city">Muscat</addr-line>, <country>Oman</country>
</aff>
      <aff id="aff3">
<label>3</label>
<institution content-type="department">Department of Pediatric Pulmonology</institution>, <institution>The Royal Hospital</institution>, <addr-line content-type="city">Muscat</addr-line>, <country>Oman</country>
</aff>
      <aff id="aff4">
<label>4</label>
<institution content-type="department">Pediatric Neurology and Metabolic division</institution>, <institution>Cairo University Childrens Hospital</institution>, <addr-line content-type="city">Cairo</addr-line>, <country>Egypt</country>
</aff>
      <aff id="aff5">
<label>5</label>
<institution content-type="department">Department of Pediatrics</institution>, <institution>Salmaniya Medical Complex</institution>, <addr-line content-type="city">Manama</addr-line>, <country>Bahrain</country>
</aff>
      <aff id="aff6">
<label>6</label>
<institution>Farabi Medical Laboratory</institution>, <addr-line content-type="city">Erbil</addr-line>, <country>Iraq</country>
</aff>
      <aff id="aff7">
<label>7</label>
<institution>Hawler Medical University College of Medicine</institution>, <addr-line content-type="city">Erbil</addr-line>, <addr-line content-type="state">Kurdistan</addr-line>, <country>Iraq</country>
</aff>
      <aff id="aff8">
<label>8</label>
<institution content-type="department">Pulmonology Unit, Department of Pediatrics</institution>, <institution>College of Medicine, King Saud University</institution>, <addr-line content-type="city">Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
      <aff id="aff9">
<label>9</label>
<institution content-type="department">Medical Genomic Research department</institution>, <institution>King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs (MNG-HA)</institution>, <addr-line content-type="city">Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
      <aff id="aff10">
<label>10</label>
<institution content-type="department">Genetics and Precision Medicine department (GPM)</institution>, <institution>King Abdullah Specialized Children's Hospital (KASCH), King Abdulaziz Medical City, Ministry of National Guard Health Affairs (MNG-HA)</institution>, <addr-line content-type="city">Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
      <aff id="aff11">
<label>11</label>
<institution content-type="department">Immunology Research laboratory, Department of Pediatrics</institution>, <institution>College of Medicine and King Saud University Medical City, King Saud University</institution>, <addr-line content-type="city">Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
      <aff id="aff12">
<label>12</label>
<institution content-type="department">Centre for Molecular and Biomolecular Informatics</institution>, <institution>Radboudumc, Radboud Institute for Molecular Life Sciences</institution>, <addr-line content-type="city">Nijmegen</addr-line>, <addr-line content-type="state">Gelderland</addr-line>, <country>Netherlands</country>
</aff>
      <aff id="aff13">
<label>13</label>
<institution content-type="department">Department of Pediatric Gastroenterology</institution>, <institution>Children's Hospital of Lahore</institution>, <addr-line content-type="city">Lahore</addr-line>, <country>Pakistan</country>
</aff>
      <aff id="aff14">
<label>14</label>
<institution content-type="department">Medical Genetics Department</institution>, <institution>College of Medicine, King Saud University</institution>, <addr-line content-type="city">Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
      <aff id="aff15">
<label>15</label>
<institution content-type="department">Department of Pathology</institution>, <institution>College of Medicine, King Saud University Medical City, King Saud University</institution>, <addr-line content-type="city">Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
      <aff id="aff16">
<label>16</label>
<institution content-type="department">Department of Pediatrics</institution>, <institution>King Abdullah Specialized Children's Hospital (KASCH), King Abdulaziz Medical City, Ministry of National Guard Health Affairs (MNG-HA)</institution>, <addr-line content-type="city">Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
      <author-notes>
        <corresp>
<label>Correspondence to</label> Dr Aida Bertoli-Avella, Centogene GmbH, Rostock, Germany; <email>Aida.Bertoli-Avella@centogene.com</email>
</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>10</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>12</month>
        <year>2021</year>
      </pub-date>
      <volume>59</volume>
      <issue>10</issue>
      <fpage>993</fpage>
      <lpage>1001</lpage>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>8</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>12</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</copyright-statement>
        <copyright-year>2022</copyright-year>
        <ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense" start_date="2021-12-24">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:&#xA0;<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <self-uri xlink:title="pdf" xlink:href="jmedgenet-2021-108150.pdf"/>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p>We sought to describe a disorder clinically mimicking cystic fibrosis (CF) and to elucidate its genetic cause.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Exome/genome sequencing and human phenotype ontology data of nearly 40&#x2009;000 patients from our Bio/Databank were analysed. RNA sequencing of samples from the nasal mucosa from patients, carriers and controls followed by transcriptome analysis was performed.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>We identified 13 patients from 9 families with a CF-like phenotype consisting of recurrent lower respiratory infections (13/13), failure to thrive (13/13) and chronic diarrhoea (8/13), with high morbidity and mortality. All patients had biallelic variants in <italic toggle="yes">AGR2</italic>, (1) two splice-site variants, (2) gene deletion and (3) three missense variants. We confirmed aberrant <italic toggle="yes">AGR2</italic> transcripts caused by an intronic variant and complete absence of <italic toggle="yes">AGR2</italic> transcripts caused by the large gene deletion, resulting in loss of function (LoF). Furthermore, transcriptome analysis identified significant downregulation of components of the mucociliary machinery (intraciliary transport, cilium organisation), as well as upregulation of immune processes.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>We describe a previously unrecognised autosomal recessive disorder caused by <italic toggle="yes">AGR2</italic> variants. <italic toggle="yes">AGR2</italic>-related disease should be considered as a differential diagnosis in patients presenting a CF-like phenotype. This has implications for the molecular diagnosis and management of these patients. AGR2 LoF is likely the disease mechanism, with consequent impairment of the mucociliary defence machinery. Future studies should aim to establish a better understanding of the disease pathophysiology and to identify potential drug targets.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>genetics</kwd>
        <kwd>RNA-Seq</kwd>
        <kwd>genetic research</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>special-feature</meta-name>
          <meta-value>unlocked</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p>Cystic fibrosis (CF (OMIM 219700)) is characterised by a triad of chronic obstructive pulmonary disease, exocrine pancreatic insufficiency and elevation of sodium and chloride concentration in sweat caused by biallelic pathogenic variants in the <italic toggle="yes">CFTR</italic> gene.<xref rid="R1" ref-type="bibr">1 2</xref> The disorder was first described in 1938<xref rid="R3" ref-type="bibr">3</xref> and was originally known as mucoviscidosis, given the observation that the patients presented abnormally thick mucus (reviewed in a previous work<xref rid="R4" ref-type="bibr">4</xref>).</p>
      <p>Mucus is an essential polymer secreted mainly by specialised cells in the respiratory and digestive tracts. It plays a vital role in the protection against infectious and toxic agents by clearing debris and pathogens through mucociliary clearance. Furthermore, mucus also protects the sensitive epithelial surfaces in the airways and intestine.<xref rid="R5" ref-type="bibr">5</xref> Mucins are the major macromolecular constituents of epithelia mucus and play a relevant role in health and disease.<xref rid="R6" ref-type="bibr">6</xref> The secreted or gel-forming mucins are responsible for the viscoelasticity of mucus, with MUC5B and MUC5AC being the major gel-forming mucins present in the airways, where they have different airway clearance functionalities.<xref rid="R7" ref-type="bibr">7 8</xref> In the small intestine and colon, MUC2 forms the layer of mucus and is responsible for the protection of the gut barrier, the regulation of microbiome homeostasis and the prevention of diseases.<xref rid="R9" ref-type="bibr">9 10</xref>
</p>
      <p>Within this study, we present 13 patients from 9 unrelated families suffering from a previously undescribed genetic disorder characterised by recurrent lower respiratory infections, chronic diarrhoea and failure to thrive&#x2014;a phenotype clinically resembling cystic fibrosis (CF). By performing exome/genome sequencing (ES/GS) and an analysis of our rare disease-centric Bio/Databank, we identified six different <italic toggle="yes">AGR2</italic> biallelic variants as disease-causing for these patients. In mice, Agr2 is relevant for the normal functioning of mucins from the respiratory and gastrointestinal tract,<xref rid="R11" ref-type="bibr">11&#x2013;13</xref> suggesting that <italic toggle="yes">AGR2</italic>-related disease might be a novel mucus disorder.</p>
    </sec>
    <sec sec-type="methods" id="s2">
      <title>Methods</title>
      <p>This project has been conducted within a diagnostic setting, and as a second step, used deidentified data and samples. Thus, this did not require institutional review board (IRB) approval in our jurisdiction. Written informed consent was obtained from all nine families for genetic studies as well as for scientific publication of anonymised clinical data and clinical photographs. Additionally, the consent declaration included information regarding storage of the data and further processing for research purposes. The informed consent form is available in English and several other languages (<ext-link xlink:href="https://www.centogene.com/downloads.html" ext-link-type="uri">https://wwwcentogenecom/downloadshtml</ext-link>).</p>
      <sec id="s2-1">
        <title>Exome sequencing (ES)</title>
        <p>DNA was extracted using standard methods from dried blood spots (DBS) submitted on filter cards (CentoCard&#xAE;). Details of the laboratory procedures, bioinformatics analysis and evaluation of the exome data are provided in the Supplemental data. <italic toggle="yes">AGR2</italic> exon numbering was based on transcript NM_006408.3 (8 exons). Variant nomenclature followed standard Human Genome Variation Society recommendations.</p>
      </sec>
      <sec id="s2-2">
        <title>Analysis of proprietary Bio/Databank</title>
        <p>Our Bio/Databank<xref rid="R14" ref-type="bibr">14</xref> contains data from 65&#x2009;005 individuals with ES and/or GS data, as well as corresponding clinical information, which is registered in the Bio/Databank as human phenotype ontology (HPO) terms. A total of 39&#x2009;756 of these individuals are patients with at least one HPO term used for phenotype description. After identification of <italic toggle="yes">AGR2</italic> as a candidate gene in the first family, the Bio/Databank was investigated for rare biallelic variants in the <italic toggle="yes">AGR2</italic> gene (ExAC/gnomAD&lt;1%). Variants with high or moderate predicted impact on protein structure or function (CADD raw score &#x2265;4) were prioritised. For the identified cases, HPOs, all available clinical information, and test results were reviewed to elucidate the associated phenotype. The ES and/or GS data were reanalysed to investigate whether other variants could contribute to the phenotype of the patients. Referring clinicians were then recontacted (for cases with consent provided).</p>
      </sec>
      <sec id="s2-3">
        <title>RNA sequencing and data analysis</title>
        <p>Nasal swabs were taken for the probands (families 2, 3, 4, 6, 7 and 8) using ORE-100 RNA collection kits (Steinbrenner Laborsysteme GmbH), and RNA was extracted with the Quick-RNA micro prep kit (Zymogen) following manufacturer&#x2019;s instructions. The TruSeq stranded mRNA kit (Illumina) was used to generate next-generation sequencing (NGS) barcoded libraries. After pooling, the libraries were sequenced on a NextSeq 500 system using the 75&#x2009;bp paired-end protocol. An average of 34&#x2009;052&#x2009;907 reads (&gt;Q30) were obtained for each sample. RNA-seq reads were aligned using two-pass mode with STAR V.2.7.6a<xref rid="R15" ref-type="bibr">15</xref> against human genome GRCh37/Release 38 (<ext-link xlink:href="www.gencodegenes.org" ext-link-type="uri">www.gencodegenes.org</ext-link>). The read groups were fixed, and the duplicates were marked using Picard tools V.2.23.8. Counting the reads was performed by featureCounts/subread V.2.0.1.<xref rid="R16" ref-type="bibr">16</xref> Initial quality control and differential expression analysis was performed with DESeq2_1.32.0,<xref rid="R17" ref-type="bibr">17</xref> and pathway analysis was performed with ToppGene.<xref rid="R18" ref-type="bibr">18</xref>
</p>
        <p>Total RNA was converted to cDNA using reverse transcriptase Superscript IV (Invitrogen). Primers were designed to amplify <italic toggle="yes">AGR2</italic> fragments from exons 1&#x2013;8, 2&#x2013;6 and 4&#x2013;7 (primer sequences available on request). After PCR, aliquots were electrophoresed on 1% agarose gels at 90 V for 90&#x2009;min, stained with SYBR safe (Invitrogen).</p>
      </sec>
      <sec id="s2-4">
        <title>Protein structural analysis</title>
        <p>Experimentally solved structures for both the monomeric and dimeric conformations of AGR2 can be found in the Protein Data Bank. These files, PDB-codes 2LNT and 2LNS, respectively, contain the C-terminal residues 36&#x2013;175. We used the YASARA<xref rid="R19" ref-type="bibr">19</xref> and WHAT IF software<xref rid="R20" ref-type="bibr">20</xref> to study these structures.</p>
      </sec>
      <sec id="s2-5">
        <title>Ceramide26 quantification in DBS</title>
        <p>C26 Ceramide species were quantified in DBS extracts using a method previously described,<xref rid="R21" ref-type="bibr">21</xref> as well as multiple reaction monitoring mass spectrometry.</p>
        <p>A detailed methods description can be found in the Supplemental data.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="s3">
      <title>Results</title>
      <sec id="s3-1">
        <title>Clinical description of the affected individuals</title>
        <p>Thirteen patients from nine families presented with a similar CF-like phenotype consisting of recurrent respiratory infections, chronic diarrhoea and failure to thrive (<xref rid="SP1" ref-type="supplementary-material">online supplemental table 1</xref>). The patients&#x2019; ages ranged from 10 months to 10 years old. Symptoms started usually around the neonatal period. The children suffered from recurrent coughing, wheezy episodes, pneumonia, interstitial lung disease and bronchiectasis. Further episodes of vomiting and chronic diarrhoea led to poor weight gain. Additionally, four patients presented hepatosplenomegaly, and two had cardiovascular abnormalities (mitral valve insufficiency and right heart failure with severe pulmonary hypertension). Most patients had appropriate neurodevelopment; only two cases presented developmental issues. Respiratory and gastrointestinal complaints caused frequent and prolonged hospital admissions. Family history was positive in four families (out of eight) with several similarly affected relatives. Sweat chloride tests and pancreatic elastase results were normal (when performed). Two patients had cultures positive for <italic toggle="yes">Pseudomonas</italic>. Patient III-1 (family 6) had a bronchoalveolar lavage cytology that showed cellular fluid composed of bronchial epithelial cells and alveolar macrophages with strands of thick mucus. Nasal ciliary brush study was done in two patients, with motile cilia seen under light microscopy with 9+2 normal configuration (family 6 and family 7). However, ultrastructural electron microscopy analysis of a nasal brush sample (family 8) detected ciliary abnormalities in 34% of the 189 examined transverse cilia sections. The abnormalities were related to missing central doubles, triplets instead of central doubles with missing dynein arms (inner and/or outer) at peripheral doubles, and duplication of central doublets with missing dynein arms (inner and/or outer) at peripheral doublets (<xref rid="SP2" ref-type="supplementary-material">online supplemental figure 1</xref>). This result was considered as inconclusive since in patients with a primary ciliary defect, most cilia would be expected to be abnormal.<xref rid="R22" ref-type="bibr">22</xref>
</p>
        <supplementary-material id="SP1" position="float" content-type="local-data">
          <object-id pub-id-type="doi">10.1136/jmedgenet-2021-108150.supp1</object-id>
          <label>Supplementary data</label>
          <p>
<inline-supplementary-material id="SS1" xlink:href="jmedgenet-2021-108150supp001.xlsx" content-type="local-data"/>
</p>
        </supplementary-material>
        <supplementary-material id="SP2" position="float" content-type="local-data">
          <object-id pub-id-type="doi">10.1136/jmedgenet-2021-108150.supp2</object-id>
          <label>Supplementary data</label>
          <p>
<inline-supplementary-material id="SS2" xlink:href="jmedgenet-2021-108150supp002.pdf" content-type="local-data"/>
</p>
        </supplementary-material>
        <p>Additional clinical data can be found in the supplementary data (<xref rid="SP2" ref-type="supplementary-material">online supplemental table 1</xref> and Clinical summaries).</p>
      </sec>
      <sec id="s3-2">
        <title>Exome and Bio/Databank analyses</title>
        <p>In family 1, exome analysis focused on &#x2018;diagnostic&#x2019; genes which did not detect any relevant variant. We then performed an extended exome analysis focusing on genes not yet linked to a human phenotype. Given the positive family history and parental consanguinity, we prioritised homozygous variants. Eight variants were identified (<xref rid="SP2" ref-type="supplementary-material">online supplemental table 2</xref>), from which the novel missense variant in the <italic toggle="yes">AGR2</italic> gene (NM_006408.3:c.211C&gt;A, p.Pro71Thr) was selected as the best candidate given its rarity, high conservation, and known function and protein localization.<xref rid="R12" ref-type="bibr">12 13 23</xref> Targeted testing confirmed that the parents were heterozygote carriers, and both affected cousins were homozygotes for the same variant, fully co-segregating with the disease (<xref rid="F1" ref-type="fig">figure 1</xref>).</p>
        <fig position="float" id="F1">
          <label>Figure 1</label>
          <caption>
            <p>Summarised family trees of the nine families and the identified <italic toggle="yes">AGR2</italic> variants. Variants are colour-coded, the founder missense variant is shown in red font, with the corresponding haplotypes (families 2, 3, 4 and 7). Genotypes are shown below available individuals. <italic toggle="yes">AGR2</italic> genotypes show full co-segregation with the phenotype.</p>
          </caption>
          <graphic xlink:href="jmedgenet-2021-108150f01" position="float"/>
        </fig>
        <p>This finding prompted us to mine our Bio/Databank to identify additional cases with overlapping phenotypes, no genetic diagnosis established, and rare biallelic variants in the <italic toggle="yes">AGR2</italic> gene. Exome/genome data from 39&#x2009;756 patients was investigated. We prioritised <italic toggle="yes">AGR2</italic> rare, homozygous and compound heterozygous variants, with predicted impact on the protein. Additionally, we searched for copy number variants (CNVs) affecting the <italic toggle="yes">AGR2</italic> gene.</p>
        <p>This resulted in the identification of a total of 13 patients from nine families (<xref rid="F1" ref-type="fig">figure 1</xref> and <xref rid="SP2" ref-type="supplementary-material">online supplemental table 1</xref>). All patients presented with very similar phenotypic features, mainly including recurrent lower respiratory tract infections, and no evident immunological abnormalities. Relevant rare homozygous variants are shown in <xref rid="SP2" ref-type="supplementary-material">online supplemental table 2</xref>. The missense variant in exon 6 of <italic toggle="yes">AGR2</italic> (NM_006408.3:c.349C&gt;T, p.His117Tyr) was present in patients from families 2, 3, 4 and 7. Analysis of the genomic region around <italic toggle="yes">AGR2</italic> indicated a shared haplotype for these families (from rs71523042 to rs780638101, 2.8&#x2009;Mb), suggesting a common ancestor. Families 2, 4 and 7, from Syrian origin, had a larger shared chromosomal region of approximately 8.2&#x2009;Mb (<xref rid="F1" ref-type="fig">figure 1</xref>). An additional missense variant was identified in family 9 (c.428G&gt;A, p.Gly143Glu).</p>
        <p>We also detected two splice site variants (NM_006408.3:c.330+1G&gt;T&#x2009;and c.330+1del) in families 5 and 8, respectively. The variant was confirmed as heterozygous in the parents and unaffected sibling and homozygous in the similarly affected brother in family 5 (<xref rid="F1" ref-type="fig">figure 1</xref>). The index from family 8 is adopted, and no biological relatives could be tested. The variants affect the canonical splicing site and are predicted to abolish normal exon 5 splicing.</p>
        <p>Furthermore, we identified a large homozygous deletion including exon 1 to exon 7 of the <italic toggle="yes">AGR2</italic> gene and affecting the neighbouring gene <italic toggle="yes">AGR3</italic> in family 6 (full gene deletion, genomic coordinates chr7:16,834,229&#x2013;16,936,407, <xref rid="F2" ref-type="fig">figure 2A</xref>). This prompted us to query our Bio/Databank for potential causative variants in <italic toggle="yes">AGR3</italic>. We identified several individuals with homozygous missense, splicing and nonsense variants in <italic toggle="yes">AGR3</italic>. However, these variants were present in unaffected adults (parents) and patients with variable phenotypes not overlapping with the clinical features of the patients described in this study. Therefore, these data do not support a causative effect of <italic toggle="yes">AGR3</italic> variants.</p>
        <fig position="float" id="F2">
          <label>Figure 2</label>
          <caption>
            <p>
<italic toggle="yes">AGR2</italic> variants identified in the patients and abnormal splicing caused by an intronic variant. (A) The deletion region of <italic toggle="yes">AGR2/3</italic> is shown in the Integrative Genome Viewer (IGV). Reads for the exonic regions of the <italic toggle="yes">AGR2/3</italic> genes can be seen in the control (lower panel), whereas no reads are seen in the index sample III-1 (deleted region is boxed, chr7:16834456&#x2013;16918247). This deletion was confirmed by qPCR. (B) Schematic representation of <italic toggle="yes">AGR2</italic> gene, with the detected variants shown (font colours match the respective family). (C) Sashimi plots from IGV, illustrating <italic toggle="yes">AGR2</italic> splicing junctions. Arcs represents splice junctions and connect the exons, the number of reads split is displayed across the junction. The variant c.330+1del causes aberrant splicing, note the junctions skipping exon 5 (arrow). See also <xref rid="SP2" ref-type="supplementary-material">online supplemental figure 2A&#x2013;C</xref>.</p>
          </caption>
          <graphic xlink:href="jmedgenet-2021-108150f02" position="float"/>
        </fig>
        <p>We also searched other data repositories for variants, such as gnomAD (v2.1.1) and Decipher for <italic toggle="yes">AGR2</italic> variants (SNVs and CNVs). Genes related to autosomal recessive diseases are relatively unconstrained.<xref rid="R24" ref-type="bibr">24</xref> However, loss of function (LoF) variants in <italic toggle="yes">AGR2</italic> are ultrarare, with not a single individual reported as homozygote in these data repositories. The variants detected in our patients are novel or ultrarare in gnomAD, with high conservation and CADD scores supporting adverse consequences (<xref rid="SP2" ref-type="supplementary-material">online supplemental table 3</xref>).</p>
      </sec>
      <sec id="s3-3">
        <title>RNA sequencing analysis</title>
        <p>The AGR2 protein is mainly detected in mucus-secreting organs from the gastrointestinal tract, the respiratory tract and the reproductive system.<xref rid="R23" ref-type="bibr">23</xref> To assess the effect of the splicing variant and the large deletion and to learn about the putative affected pathways, we performed RNA sequencing using RNA isolated from the nasal mucosa from 6 patients, 4 heterozygote carriers and 11 controls. RNA sequencing confirmed that the c.330+1del variant causes aberrant splicing of <italic toggle="yes">AGR2</italic>, disturbing exon 5 splicing with retention of intronic regions and altering the reading frame, finally leading to LoF (<xref rid="F2" ref-type="fig">figure 2C</xref> and <xref rid="SP2" ref-type="supplementary-material">online supplemental figure 2AC</xref>). Abnormal splicing was confirmed by targeted <italic toggle="yes">AGR2</italic> RT-PCR (<xref rid="SP2" ref-type="supplementary-material">online supplemental figure 2B</xref>). We also confirmed that the large deletion detected in the index patient from family 6 leads to a complete loss of <italic toggle="yes">AGR2</italic> transcripts (<xref rid="SP2" ref-type="supplementary-material">online supplemental figure 2C</xref>). Both patients had very low to nearly no <italic toggle="yes">AGR2</italic> expression (adjusted p value=0.002), confirming that both variants are leading to LoF. For the founder missense variant c.349C&gt;T, there is no evident splicing effect (<xref rid="F2" ref-type="fig">figure 2C</xref> and <xref rid="SP2" ref-type="supplementary-material">online supplemental figure 2A-C</xref>). Additionally, differential gene expression analysis detected biological processes that were significantly dysregulated in the patients compared with control and carrier samples. Processes such as cell/leucocyte activation and others related to the immune system were transcriptionally upregulated, whereas processes such as microtubule-based movement, process, transport and cilium organisation were significantly downregulated (<xref rid="SP1" ref-type="supplementary-material">online supplemental file 1</xref>). As an exploratory analysis, we evaluated differential gene expression in the two patients with proven LoF variants (large gene deletion and c.330+1del) compared with the controls. Two relevant mucins (<italic toggle="yes">MUC2</italic> and <italic toggle="yes">MUC5AC</italic>) and <italic toggle="yes">CLCA2</italic> (from the calcium-dependent chloride channel family) are at the top of the downregulated genes (<xref rid="SP1" ref-type="supplementary-material">online supplemental file 1</xref>).</p>
      </sec>
      <sec id="s3-4">
        <title>Protein structural analysis (missense variants)</title>
        <p>Based on the published AGR2 protein structure,<xref rid="R25" ref-type="bibr">25</xref> we investigated the possible effects of the missense variants p.Pro71Thr, p.His117Tyr and p.Gly143Glu. We first examined whether the variants could directly affect dimer formation. The Pro71 residue is semi-buried in the core of the protein, whereas the His117 and Gly143 occur in surface loops but are not immediately at the dimerisation face (<xref rid="F3" ref-type="fig">figure 3A and B</xref>). For Pro71Thr, the proline side chain is slightly larger than threonine; the main differences between these two residues lie in the tendency of the proline residue to make rigid turns that stabilise the protein structure (<xref rid="F3" ref-type="fig">figure 3C</xref>). A substitution of histidine by tyrosine would result in loss of an amino acid that can potentially store electrons (<xref rid="F3" ref-type="fig">figure 3D</xref>). Lastly, Gly143Glu is a clear example of the introduction of a larger side chain that will no longer fit at that position. Glutamic acid with its charged &#x3B3;-carboxyl side chain would be disruptive and large compared with the glycine with its single hydrogen side chain (<xref rid="F3" ref-type="fig">figure 3E</xref>). This change will affect the local structure simply by restructuring the surrounding residues to remove steric clashes, and may affect interactions with other proteins by changing the surface of AGR2.</p>
        <fig position="float" id="F3">
          <label>Figure 3</label>
          <caption>
            <p>Structural protein analysis of the missense variants. (A) Dimer of the AGR2 residues 36&#x2013;175. Monomers are individually coloured in grey or blue. Side chains of the residues are not shown, except for the mutated P71, H117 and G143 in red. (B) Overview of AGR2 as seen from the side; one monomer is shown as grey surface only. This view shows the distance between the mutated residues (red side chains) and the putative active site of the protein CPHS-motif (orange). (C) Variant P71T: The proline side chain is shown in magenta; note the attachment of the side chain to its own backbone; the threonine side chain is shown in yellow. Side chains of the protein are coloured by atom type (carbon=cyan, oxygen=red, nitrogen=blue, sulfur=green). The proline side chain is slightly larger than threonine, but the main differences between these two residues lie in the shape of the side chain and proline tendency to make rigid turns that stabilise the protein structure. (D) Variant H117Y: The histidine side chain is shown in magenta, whereas the tyrosine side chain is yellow. Other atoms are coloured as described. The change from histidine to tyrosine indicates a small difference in size, and a different potential for interactions since histidine&#x2019;s side chain can be used for electron storage. (E) Variant G143E: The side chain of the mutant residue glutamic acid will not fit in the same space (note that wild-type glycine does not have a side chain). The change in charge and side chain size will affect the local structure and may affect interactions with other proteins.</p>
          </caption>
          <graphic xlink:href="jmedgenet-2021-108150f03" position="float"/>
        </fig>
      </sec>
      <sec id="s3-5">
        <title>Whole blood ceramides (Cer26) analysis</title>
        <p>Lipid metabolism imbalances have been consistently reported in patients with CF, as measured in plasma,<xref rid="R26" ref-type="bibr">26</xref> human primary bronchial cells<xref rid="R27" ref-type="bibr">27</xref> and mesenchymal stem cells.<xref rid="R28" ref-type="bibr">28</xref> Among sphingolipids, ceramide is emerging as one of the players of the pulmonary dysfunction in inflammatory lung diseases; enhanced sphingolipid metabolism leads to an increased ceramide content, which in turn contributes to maintaining the chronic inflammatory status.<xref rid="R28" ref-type="bibr">28</xref> We measured the levels of ceramide26 (Cer26) in DBS from patients with homozygous biallelic variants in <italic toggle="yes">AGR2</italic> (n=5), in molecularly confirmed patients with CF (n=11) and healthy controls (n=10). Patients with CF had slightly lower Cer26 levels, but this difference was not significant. All four <italic toggle="yes">AGR2</italic> patients with severe pulmonary disease consistently showed pathologically elevated levels of Cer26cis, Cer26trans and Cer26total isomers, while the patient with mild respiratory symptoms showed normal levels (family 3). Taken as a whole, the <italic toggle="yes">AGR2</italic> patient group had significantly elevated levels of all measured Cer26 isomers when compared with patients with CF and healthy controls (Cer26total F=10.94, p&lt;0.001; <xref rid="SP2" ref-type="supplementary-material">online supplemental figure 3</xref>). These findings suggest an altered Cer26 metabolism in patients with <italic toggle="yes">AGR2</italic>-related disease.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s4">
      <title>Discussion</title>
      <p>By combining ES and Bio/Databank analyses, we identified 13 patients from 9 families with rare homozygous variants in <italic toggle="yes">AGR2</italic> (<xref rid="F1 F2" ref-type="fig">figures 1 and 2</xref>). Three of these variants are very likely leading to a LoF (affecting canonical splicing site and large gene deletion), suggesting that loss of AGR2 is likely causing the phenotype in at least a subset of these patients. Affected individuals presented very early in life with recurrent coughing, wheezing, low tract respiratory infections, chronic diarrhoea and failure to thrive which resembled CF (<xref rid="SP2" ref-type="supplementary-material">online supplemental table 1</xref>). However, these patients presented normal sweat/elastase tests. Although four of them presented hepatomegaly with undetermined cause, meconium ileus, pancreatic insufficiency, steatorrhea or pancreatitis were not reported in our patients. Thus, on a closer look, CF can be clinically excluded in these patients. This was later confirmed by genetic testing with no relevant variants detected in the <italic toggle="yes">CFTR</italic> gene. From a clinical perspective, it is important to consider AGR2-related disease as a differential diagnosis of patients presenting a CF-like phenotype (and normal sweat/elastase tests).</p>
      <p>Interestingly, the index case from family 8 presented cilia abnormalities in the nasal epithelium (<xref rid="SP2" ref-type="supplementary-material">online supplemental figure 1</xref>), although these could be secondary cilia changes, as described also in CF and chronic bronchitis.<xref rid="R29" ref-type="bibr">29</xref> Together with our results from the RNA differential expression and pathway analysis, cilia abnormalities may occur as part of the <italic toggle="yes">AGR2-</italic>related phenotype; however, more patients would need to be examined.</p>
      <p>The AGR2 protein is detected at high levels in tissues that secrete mucus or function as endocrine organs, including the respiratory tract, stomach, colon, prostate and small intestine (reviewed in a previous work<xref rid="R23" ref-type="bibr">23</xref>). At the cellular level, AGR2 is expressed in Paneth and goblet cells (intestine/colon), ciliated cells (airways) and glandular cells (pancreas and prostate, among others)<xref rid="R12" ref-type="bibr">12 30 31</xref> (Human Protein Atlas, <ext-link xlink:href="http://www.proteinatlas.org" ext-link-type="uri">http://www.proteinatlas.org</ext-link>). Subcellularly, AGR2 localises to the lumen of the endoplasmic reticulum (ER), indirectly associates with ER membrane-bound ribosomes, and it is involved in the maintenance of ER homeostasis. Knockdown of AGR2 significantly alters the expression of components of the ER-associated degradation machinery and reduces the ability of cells to cope with acute ER stress.<xref rid="R32" ref-type="bibr">32</xref>
</p>
      <p>AGR2 is required for adequate production of intestinal mucin MUC2 and airway mucins MUC5B and MUC5AC.<xref rid="R11" ref-type="bibr">11&#x2013;13 33</xref> Mouse Muc5b is required for mucociliary clearance, for controlling infections in the airways and middle ear, and for maintaining immune homeostasis in mouse lungs, whereas Muc5ac is dispensable.<xref rid="R34" ref-type="bibr">34</xref> On the other hand, MUC2 is the major intestinal mucin,<xref rid="R11" ref-type="bibr">11 35</xref> and it has been implicated in inflammatory bowel disease and colorectal cancer.<xref rid="R36" ref-type="bibr">36 37</xref>
<italic toggle="yes">Agr2</italic> knockout mice are born healthy but are unable to produce intestinal mucin and are highly susceptible to experimentally induced colitis, with profound weight loss and intestinal bleeding suggesting a role of Agr2 in protection from disease. With ageing, <italic toggle="yes">Agr2</italic> knockout mice develop rectal prolapse, a feature observed in mouse models with colitis.<xref rid="R11" ref-type="bibr">11</xref> Extensive spontaneous ileitis and colitis were also described in mice lacking Agr2.<xref rid="R12" ref-type="bibr">12</xref> Schroeder <italic toggle="yes">et al</italic> described a considerable reduction of Muc5ac and Muc5b in the airways of allergen challenged <italic toggle="yes">Agr2</italic>-deficient mice, with abnormal allergen response compared with wild-type controls. This is likely due to impaired mucin transit through the ER, where these mucins were found to accumulate.<xref rid="R13" ref-type="bibr">13</xref>
</p>
      <p>Thus, the evidence presented in the studies of the Agr2-deficient mice points to an important role of Agr2 in mucin/mucus production, as well as homeostasis of the respiratory and intestinal tract. These findings are also compatible with the phenotype observed in the patients described in this study and support the hypothesis that the detected variants are likely acting via a LoF mechanism.</p>
      <p>Interestingly, one patient presented a large homozygous deletion affecting seven out of eight exons of <italic toggle="yes">AGR2</italic> and the complete <italic toggle="yes">AGR3</italic> gene. The Agr3 protein is detected in ciliated cells in the airway epithelium, and unlike Agr2, it is not induced by ER stress. Mice lacking Agr3 are viable and develop ciliated cells with normal-appearing cilia, which have reduced ciliary beat frequency in the airways, associated with impaired mucociliary clearance in Agr3-deficient animals.<xref rid="R38" ref-type="bibr">38</xref> No differences in phenotype were observed between the patient with the homozygous <italic toggle="yes">AGR2-AGR3</italic> deletion and the rest of the patients. Cases with <italic toggle="yes">AGR3</italic> biallelic variants and overlapping phenotypes have not been described, to our knowledge.</p>
      <p>Pathway transcriptome analysis of nasal samples from patients, carriers and healthy controls detected upregulated biological processes such as immune response, leucocyte activation and immune effector processes which could be related to the recurrent airway infections suffered by the patients. Further, downregulation of cilia-related processes (intraciliary transport, microtubule-based transport, cilium organisation) could also reflect a defective cilia function in the patients. This could be secondary to a primary mucus abnormality.</p>
      <p>Interestingly, a recent article reports two siblings with severe congenital enteropathy, but also recurrent respiratory infections and wheezing&#x2014;a phenotype that overlaps with the clinical features of our patients. The siblings had the same homozygous missense founder variant (c.349C&gt;T, p.His117Tyr) reported in five of our patients. The authors detected very low levels of MUC2 protein in the intestinal wall of the patients.<xref rid="R30" ref-type="bibr">30</xref> They found high levels of mislocalised AGR2 protein in the epithelial surfaces of gastric and bowel sections of the patients compared with controls. In our transcriptome analysis, no significant differences in mRNA <italic toggle="yes">AGR2</italic> expression were detected when comparing average <italic toggle="yes">AGR2</italic> expression in patients, with carriers, or controls. Combining this information, this suggests that the mutant AGR2 (His117Tyr) protein is produced but has impaired functionality, probably leading to accumulation and mislocalisation at the affected epithelia. Since AGR2 is essential for MUC2/mucus production,<xref rid="R11" ref-type="bibr">11</xref> loss of AGR2 functioning could explain the low levels of MUC2 protein detected intestinal mucosa of the patients compared with controls.<xref rid="R30" ref-type="bibr">30</xref> This also aligns with our transcriptome differential gene expression analysis focused on the patients with proven LoF variants, which showed significantly reduced levels of <italic toggle="yes">AGR2</italic>, but also <italic toggle="yes">MUC2</italic> and <italic toggle="yes">MUC2AC</italic>. Interestingly, this analysis also showed a significant reduction of <italic toggle="yes">CLCA2</italic> levels. CLCA2 belongs to the calcium-dependent chloride channel family which are involved in the regulation of electrolytic fluxes and modulate secretion, absorption, cell volume and membrane potential, predominantly expressed in the digestive tract and trachea.<xref rid="R39" ref-type="bibr">39</xref>
</p>
      <p>Based on the AGR2 structure published by Patel <italic toggle="yes">et al</italic>,<xref rid="R25" ref-type="bibr">25</xref> our structural analysis suggests that the missense variants detected in the patients could affect proper AGR2 interactions with other proteins (His117Thr) or might affect the protein structure (Pro71Thr and Gly143Glu). Importantly, His117Thr occurs roughly on the same side of the protein as Cys81. Change of Cys81 into serine is described as causing loss of interaction with Muc2.<xref rid="R11" ref-type="bibr">11</xref> This is also in line with a recent cellular model that found reduced binding of mutant AGR2 (His117Thr) to MUC2.<xref rid="R30" ref-type="bibr">30</xref>
</p>
      <p>Sphingolipid metabolism and ceramide content is altered in airway epithelial cells from patients with CF.<xref rid="R27" ref-type="bibr">27 28</xref> Ceramides are implicated in inflammation and their accumulation in CF cells was previously demonstrated.<xref rid="R40" ref-type="bibr">40</xref> In Cftr-deficient mice, ceramide accumulation leads to constitutive age-dependent pulmonary inflammation, death of respiratory epithelial cells, deposits of DNA in bronchi and high susceptibility to severe <italic toggle="yes">Pseudomonas</italic> infections.<xref rid="R40" ref-type="bibr">40</xref> We directly measured DBS extracts as validated by us previously.<xref rid="R21" ref-type="bibr">21</xref> In four out of the five <italic toggle="yes">AGR2</italic> patients, ceramide isomers (Cer26) were significantly higher than in healthy controls and patients with CF. Ceramides have been found consistently elevated in the airways of patients with CF and CF animal models, and its accumulation significantly contributes to sustained inflammation and inability to fight lung infections. Conversely, low plasma ceramides have been found in patients with CF, which has been attributed to the abnormal lipid metabolism and malabsorption (reviewed in a previous work<xref rid="R41" ref-type="bibr">41</xref>). We also detected lower Cer26 levels in patients with CF, although this difference was not significant. Our findings in <italic toggle="yes">AGR2</italic> patients point to a role of ceramides, specifically Cer26 in the AGR2-disease pathophysiology. Whether this is part of a specific disease mechanism or a reflection of a systemic inflammation process, will require further investigation. Cer26 determination could potentially be used as a rapid screening method for <italic toggle="yes">AGR2</italic>-related disease.</p>
      <p>In conclusion, we describe a previously unrecognised autosomal recessive disease which is caused by biallelic variants in the <italic toggle="yes">AGR2</italic> gene, likely acting via a LoF mechanism. Paediatric patients presenting a CF-like phenotype should be tested for <italic toggle="yes">AGR2</italic>. Our findings are relevant for the early genetic diagnosis and timely clinical management of the patients&#x2014;acting as the first step to unravelling the pathophysiology of this disease.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank the patients and families for their entusiastic participation and CENTOGENE&#x2019;s colleagues and staff that efficiently supported this project.</p>
    </ack>
    <fn-group>
      <fn fn-type="other">
        <p>AB-A and RH contributed equally.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Contributors:</bold> MA-S, KAS, SA, LAMS, NAM, MB, MAS, NG, DNC, NA, MA, MA, NA, AS, MAA, HA, HC and SA referred the patients, and acquired and provided clinical data. AM, AU, SK, CP, OP, KT, RA, MR, ZH, AJ and VK processed the samples, analysed the NGS, Sanger or RNA-seq data. GMT, SF, LD and CC performed experiments and analysed the biochemistry data. HV performed the structural protein analysis. RH and AMB-A wrote the manuscript. AMB-A and PB designed and supervised the research project and the manuscript (both authors are guarantors of this publication).</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Funding:</bold> The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.</p>
      </fn>
      <fn fn-type="COI-statement">
        <p><bold>Competing interests:</bold> AB-A, RH, AU, CP, AM, GM-T, SF, LD, VK, SK, ZH, MR, RA-A, KT, AJ, OP, CC, NA and PB are employees of CENTOGENE GmbH. None of the other authors declared a potential conflict of interest.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Supplemental material:</bold> This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p>
      </fn>
    </fn-group>
    <sec sec-type="data-availability">
      <title>Data availability statement</title>
      <p>Data are available upon reasonable request. Data are available on request.</p>
    </sec>
    <sec sec-type="ethics-statement">
      <title>Ethics statements</title>
      <sec>
        <title>Patient consent for publication</title>
        <p content-type="ethics-consent-to-publish">Not applicable.</p>
      </sec>
      <sec>
        <title>Ethics approval</title>
        <p content-type="ethics-approval">The current project has been conducted within a diagnostic setting and in a second step, used deidentified data and samples, and thus did not require IRB approval in our jurisdiction. Informed consents were obtained, including specific consents for scientific publications. The form contains a section for consent for genetic testing related to the disease(s) of the patient and consent for research (related to the main concern, but implicating genes not yet associated to human diseases). Additionally, the consent declaration included information regarding storage of the data and further processing for research purposes. The informed consent form is available in English and several other languages at <ext-link xlink:href="https://www.centogene.com/download" ext-link-type="uri">https://www.centogene.com/downloads</ext-link>. Participants gave informed consent to participate in the study before taking part.</p>
      </sec>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kerem</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Rommens</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Buchanan</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Markiewicz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Cox</surname>
<given-names>TK</given-names>
</string-name>, <string-name>
<surname>Chakravarti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Buchwald</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tsui</surname>
<given-names>LC</given-names>
</string-name>
</person-group>. <article-title>Identification of the cystic fibrosis gene: genetic analysis</article-title>. <source>Science</source>
<year>1989</year>;<volume>245</volume>:<fpage>1073</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1126/science.2570460</pub-id>
<pub-id pub-id-type="pmid">2570460</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Riordan</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Rommens</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Kerem</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Alon</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Rozmahel</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Grzelczak</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zielenski</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lok</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Plavsic</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Chou</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Drumm</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Iannuzzi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Collins</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Tsui</surname>
<given-names>LC</given-names>
</string-name>
</person-group>. <article-title>Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA</article-title>. <source>Science</source>
<year>1989</year>;<volume>245</volume>:<fpage>1066</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1126/science.2475911</pub-id>
<pub-id pub-id-type="pmid">2475911</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>ANDERSEN</surname>
<given-names>DH</given-names>
</string-name>
</person-group>. <article-title>Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study</article-title>. <source>Am J Dis Child</source>
<year>1938</year>;<volume>56</volume>:<fpage>344</fpage>&#x2013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1001/archpedi.1938.01980140114013</pub-id>
</mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Asay</surname>
<given-names>LD</given-names>
</string-name>
</person-group>. <article-title>Cystic fibrosis</article-title>. <source>Calif Med</source>
<year>1965</year>;<volume>102</volume>:<fpage>292</fpage>&#x2013;<lpage>300</lpage>.
<pub-id pub-id-type="pmid">14288148</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hansson</surname>
<given-names>GC</given-names>
</string-name>
</person-group>. <article-title>Mucus and mucins in diseases of the intestinal and respiratory tracts</article-title>. <source>J Intern Med</source>
<year>2019</year>;<volume>285</volume>:<fpage>479</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1111/joim.12910</pub-id>
<pub-id pub-id-type="pmid">30963635</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Rose</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Voynow</surname>
<given-names>JA</given-names>
</string-name>
</person-group>. <article-title>Respiratory tract mucin genes and mucin glycoproteins in health and disease</article-title>. <source>Physiol Rev</source>
<year>2006</year>;<volume>86</volume>:<fpage>245</fpage>&#x2013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00010.2005</pub-id>
<pub-id pub-id-type="pmid">16371599</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ermund</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Meiss</surname>
<given-names>LN</given-names>
</string-name>, <string-name>
<surname>Rodriguez-Pineiro</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>B&#xE4;hr</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nilsson</surname>
<given-names>HE</given-names>
</string-name>, <string-name>
<surname>Trillo-Muyo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ridley</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Thornton</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Wine</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Hebert</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Klymiuk</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Hansson</surname>
<given-names>GC</given-names>
</string-name>
</person-group>. <article-title>The normal trachea is cleaned by MUC5B mucin bundles from the submucosal glands coated with the MUC5AC mucin</article-title>. <source>Biochem Biophys Res Commun</source>
<year>2017</year>;<volume>492</volume>:<fpage>331</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2017.08.113</pub-id>
<pub-id pub-id-type="pmid">28859985</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ostedgaard</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Moninger</surname>
<given-names>TO</given-names>
</string-name>, <string-name>
<surname>McMenimen</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Sawin</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Parker</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Thornell</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Powers</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Gansemer</surname>
<given-names>ND</given-names>
</string-name>, <string-name>
<surname>Bouzek</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Cook</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Meyerholz</surname>
<given-names>DK</given-names>
</string-name>, <string-name>
<surname>Abou Alaiwa</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Stoltz</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Welsh</surname>
<given-names>MJ</given-names>
</string-name>
</person-group>. <article-title>Gel-Forming mucins form distinct morphologic structures in airways</article-title>. <source>Proc Natl Acad Sci U S A</source>
<year>2017</year>;<volume>114</volume>:<elocation-id>201703228</elocation-id>. <pub-id pub-id-type="doi">10.1073/pnas.1703228114</pub-id>
</mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Johansson</surname>
<given-names>MEV</given-names>
</string-name>, <string-name>
<surname>Sj&#xF6;vall</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hansson</surname>
<given-names>GC</given-names>
</string-name>
</person-group>. <article-title>The gastrointestinal mucus system in health and disease</article-title>. <source>Nat Rev Gastroenterol Hepatol</source>
<year>2013</year>;<volume>10</volume>:<fpage>352</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1038/nrgastro.2013.35</pub-id>
<pub-id pub-id-type="pmid">23478383</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhai</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>W</given-names>
</string-name>
</person-group>. <article-title>The role of MUC2 mucin in intestinal homeostasis and the impact of dietary components on MUC2 expression</article-title>. <source>Int J Biol Macromol</source>
<year>2020</year>;<volume>164</volume>:<fpage>884</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.07.191</pub-id>
<pub-id pub-id-type="pmid">32707285</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Park</surname>
<given-names>S-W</given-names>
</string-name>, <string-name>
<surname>Zhen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Verhaeghe</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Nakagami</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nguyenvu</surname>
<given-names>LT</given-names>
</string-name>, <string-name>
<surname>Barczak</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Killeen</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Erle</surname>
<given-names>DJ</given-names>
</string-name>
</person-group>. <article-title>The protein disulfide isomerase AGR2 is essential for production of intestinal mucus</article-title>. <source>Proc Natl Acad Sci U S A</source>
<year>2009</year>;<volume>106</volume>:<fpage>6950</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0808722106</pub-id>
<pub-id pub-id-type="pmid">19359471</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhao</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Edwards</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Dizon</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Afrasiabi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mastroianni</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Geyfman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ouellette</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Andersen</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Lipkin</surname>
<given-names>SM</given-names>
</string-name>
</person-group>. <article-title>Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2-/- mice</article-title>. <source>Dev Biol</source>
<year>2010</year>;<volume>338</volume>:<fpage>270</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2009.12.008</pub-id>
<pub-id pub-id-type="pmid">20025862</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Schroeder</surname>
<given-names>BW</given-names>
</string-name>, <string-name>
<surname>Verhaeghe</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>S-W</given-names>
</string-name>, <string-name>
<surname>Nguyenvu</surname>
<given-names>LT</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Erle</surname>
<given-names>DJ</given-names>
</string-name>
</person-group>. <article-title>Agr2 is induced in asthma and promotes allergen-induced mucin overproduction</article-title>. <source>Am J Respir Cell Mol Biol</source>
<year>2012</year>;<volume>47</volume>:<fpage>178</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2011-0421OC</pub-id>
<pub-id pub-id-type="pmid">22403803</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Trujillano</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Oprea</surname>
<given-names>G-E</given-names>
</string-name>, <string-name>
<surname>Schmitz</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Bertoli-Avella</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Abou Jamra</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Rolfs</surname>
<given-names>A</given-names>
</string-name>
</person-group>. <article-title>A comprehensive global genotype-phenotype database for rare diseases</article-title>. <source>Mol Genet Genomic Med</source>
<year>2017</year>;<volume>5</volume>:<fpage>66</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1002/mgg3.262</pub-id>
<pub-id pub-id-type="pmid">28116331</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Dobin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Davis</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Schlesinger</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Drenkow</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zaleski</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Jha</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Batut</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Chaisson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gingeras</surname>
<given-names>TR</given-names>
</string-name>
</person-group>. <article-title>Star: ultrafast universal RNA-seq aligner</article-title>. <source>Bioinformatics</source>
<year>2013</year>;<volume>29</volume>:<fpage>15</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id>
<pub-id pub-id-type="pmid">23104886</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Liao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Smyth</surname>
<given-names>GK</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>W</given-names>
</string-name>
</person-group>. <article-title>featureCounts: an efficient General purpose program for assigning sequence reads to genomic features</article-title>. <source>Bioinformatics</source>
<year>2014</year>;<volume>30</volume>:<fpage>923</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id>
<pub-id pub-id-type="pmid">24227677</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Love</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Huber</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Anders</surname>
<given-names>S</given-names>
</string-name>
</person-group>. <article-title>Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2</article-title>. <source>Genome Biol</source>
<year>2014</year>;<volume>15</volume>:<elocation-id>550</elocation-id>. <pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
<pub-id pub-id-type="pmid">25516281</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bardes</surname>
<given-names>EE</given-names>
</string-name>, <string-name>
<surname>Aronow</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Jegga</surname>
<given-names>AG</given-names>
</string-name>
</person-group>. <article-title>ToppGene suite for gene list enrichment analysis and candidate gene prioritization</article-title>. <source>Nucleic Acids Res</source>
<year>2009</year>;<volume>37</volume>:<fpage>W305</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkp427</pub-id>
<pub-id pub-id-type="pmid">19465376</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Krieger</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Koraimann</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Vriend</surname>
<given-names>G</given-names>
</string-name>
</person-group>. <article-title>Increasing the precision of comparative models with YASARA NOVA-a self-parameterizing force field</article-title>. <source>Proteins</source>
<year>2002</year>;<volume>47</volume>:<fpage>393</fpage>&#x2013;<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1002/prot.10104</pub-id>
<pub-id pub-id-type="pmid">11948792</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Vriend</surname>
<given-names>G</given-names>
</string-name>
</person-group>. <article-title>What if: a molecular modeling and drug design program</article-title>. <source>J Mol Graph</source>
<year>1990</year>;<volume>8</volume>:<fpage>52</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/0263-7855(90)80070-V</pub-id>
<pub-id pub-id-type="pmid">2268628</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cozma</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Iura&#x219;cu</surname>
<given-names>M-I</given-names>
</string-name>, <string-name>
<surname>Eichler</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hovakimyan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Brandau</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Zielke</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>B&#xF6;ttcher</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Giese</surname>
<given-names>A-K</given-names>
</string-name>, <string-name>
<surname>Lukas</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Rolfs</surname>
<given-names>A</given-names>
</string-name>
</person-group>. <article-title>C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber disease</article-title>. <source>Sci Rep</source>
<year>2017</year>;<volume>7</volume>:<elocation-id>6149</elocation-id>. <pub-id pub-id-type="doi">10.1038/s41598-017-06604-2</pub-id>
<pub-id pub-id-type="pmid">28733637</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Papon</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Coste</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Roudot-Thoraval</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Boucherat</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Roger</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Tamalet</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Vojtek</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Amselem</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Escudier</surname>
<given-names>E</given-names>
</string-name>
</person-group>. <article-title>A 20-year experience of electron microscopy in the diagnosis of primary ciliary dyskinesia</article-title>. <source>Eur Respir J</source>
<year>2010</year>;<volume>35</volume>:<fpage>1057</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.00046209</pub-id>
<pub-id pub-id-type="pmid">19840971</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Delom</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Mohtar</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Hupp</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fessart</surname>
<given-names>D</given-names>
</string-name>
</person-group>. <article-title>The anterior gradient-2 interactome</article-title>. <source>Am J Physiol Cell Physiol</source>
<year>2020</year>;<volume>318</volume>:<fpage>C40</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00532.2018</pub-id>
<pub-id pub-id-type="pmid">31644305</pub-id></mixed-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Karczewski</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Francioli</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Tiao</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Cummings</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>Alf&#xF6;ldi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Collins</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Laricchia</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Ganna</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Birnbaum</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Gauthier</surname>
<given-names>LD</given-names>
</string-name>, <string-name>
<surname>Brand</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Solomonson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Watts</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Rhodes</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Singer-Berk</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>England</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Seaby</surname>
<given-names>EG</given-names>
</string-name>, <string-name>
<surname>Kosmicki</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Walters</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Tashman</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Farjoun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Banks</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Poterba</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Seed</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Whiffin</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Chong</surname>
<given-names>JX</given-names>
</string-name>, <string-name>
<surname>Samocha</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Pierce-Hoffman</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Zappala</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>O'Donnell-Luria</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Minikel</surname>
<given-names>EV</given-names>
</string-name>, <string-name>
<surname>Weisburd</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Lek</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ware</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Vittal</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Armean</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Bergelson</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Cibulskis</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Connolly</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Covarrubias</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Donnelly</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ferriera</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gabriel</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gentry</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gupta</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Jeandet</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kaplan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Llanwarne</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Munshi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Novod</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Petrillo</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Roazen</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ruano-Rubio</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Saltzman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Schleicher</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Soto</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tibbetts</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tolonen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wade</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Talkowski</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Neale</surname>
<given-names>BM</given-names>
</string-name>, <string-name>
<surname>Daly</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>MacArthur</surname>
<given-names>DG</given-names>
</string-name>, <collab>Genome Aggregation Database Consortium</collab>
</person-group>. <article-title>The mutational constraint spectrum quantified from variation in 141,456 humans</article-title>. <source>Nature</source>
<year>2020</year>;<volume>581</volume>:<fpage>434</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2308-7</pub-id>
<pub-id pub-id-type="pmid">32461654</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Patel</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Clarke</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Barraclough</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Jowitt</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Rudland</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Barraclough</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lian</surname>
<given-names>L-Y</given-names>
</string-name>
</person-group>. <article-title>Metastasis-Promoting anterior gradient 2 protein has a dimeric thioredoxin fold structure and a role in cell adhesion</article-title>. <source>J Mol Biol</source>
<year>2013</year>;<volume>425</volume>:<fpage>929</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2012.12.009</pub-id>
<pub-id pub-id-type="pmid">23274113</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Guilbault</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wojewodka</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Saeed</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Hajduch</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Matouk</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>De Sanctis</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Radzioch</surname>
<given-names>D</given-names>
</string-name>
</person-group>. <article-title>Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide</article-title>. <source>Am J Respir Cell Mol Biol</source>
<year>2009</year>;<volume>41</volume>:<fpage>100</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2008-0279OC</pub-id>
<pub-id pub-id-type="pmid">19059886</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Loberto</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Mancini</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bassi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Carsana</surname>
<given-names>EV</given-names>
</string-name>, <string-name>
<surname>Tamanini</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pedemonte</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Dechecchi</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Sonnino</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aureli</surname>
<given-names>M</given-names>
</string-name>
</person-group>. <article-title>Sphingolipids and plasma membrane hydrolases in human primary bronchial cells during differentiation and their altered patterns in cystic fibrosis</article-title>. <source>Glycoconj J</source>
<year>2020</year>;<volume>37</volume>:<fpage>623</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1007/s10719-020-09935-x</pub-id>
<pub-id pub-id-type="pmid">32666337</pub-id></mixed-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zulueta</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Peli</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Dei Cas</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Colombo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Paroni</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Falleni</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Baisi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bollati</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Chiaramonte</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Del Favero</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ghidoni</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Caretti</surname>
<given-names>A</given-names>
</string-name>
</person-group>. <article-title>Inflammatory role of extracellular sphingolipids in cystic fibrosis</article-title>. <source>Int J Biochem Cell Biol</source>
<year>2019</year>;<volume>116</volume>. <pub-id pub-id-type="doi">10.1016/j.biocel.2019.105622</pub-id>
</mixed-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tilley</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Walters</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Shaykhiev</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Crystal</surname>
<given-names>RG</given-names>
</string-name>
</person-group>. <article-title>Cilia dysfunction in lung disease</article-title>. <source>Annu Rev Physiol</source>
<year>2015</year>;<volume>77</volume>:<fpage>379</fpage>&#x2013;<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-physiol-021014-071931</pub-id>
<pub-id pub-id-type="pmid">25386990</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Al-Shaibi</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Abdel-Motal</surname>
<given-names>UM</given-names>
</string-name>, <string-name>
<surname>Hubrack</surname>
<given-names>SZ</given-names>
</string-name>, <string-name>
<surname>Bullock</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Al-Marri</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Agrebi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Al-Subaiey</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Ibrahim</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Charles</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Elawad</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Uhlig</surname>
<given-names>HH</given-names>
</string-name>, <string-name>
<surname>Lo</surname>
<given-names>B</given-names>
</string-name>, <collab>COLORS in IBD-Qatar Study Group</collab>
</person-group>. <article-title>Human AGR2 deficiency causes mucus barrier dysfunction and infantile inflammatory bowel disease</article-title>. <source>Cell Mol Gastroenterol Hepatol</source>
<year>2021</year>;<volume>12</volume>:<fpage>1809</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmgh.2021.07.001</pub-id>
<pub-id pub-id-type="pmid">34237462</pub-id></mixed-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Thul</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>&#xC5;kesson</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wiking</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mahdessian</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Geladaki</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ait Blal</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Alm</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Asplund</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bj&#xF6;rk</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Breckels</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>B&#xE4;ckstr&#xF6;m</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Danielsson</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Fagerberg</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Fall</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gatto</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Gnann</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hober</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hjelmare</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Johansson</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lindskog</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mulder</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mulvey</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Nilsson</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Oksvold</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rockberg</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Schutten</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Schwenk</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Sivertsson</surname>
<given-names>&#xC5;sa</given-names>
</string-name>, <string-name>
<surname>Sj&#xF6;stedt</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Skogs</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Stadler</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sullivan</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Tegel</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Winsnes</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zwahlen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mardinoglu</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pont&#xE9;n</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>von Feilitzen</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Lilley</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Uhl&#xE9;n</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lundberg</surname>
<given-names>E</given-names>
</string-name>
</person-group>. <article-title>A subcellular map of the human proteome</article-title>. <source>Science</source>
<year>2017</year>;<volume>356</volume>. doi:<pub-id pub-id-type="doi">10.1126/science.aal3321</pub-id>. [Epub ahead of print: <comment>26 05 2017</comment>].
</mixed-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Higa</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mulot</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Delom</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bouchecareilh</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nguy&#xEA;n</surname>
<given-names>DT</given-names>
</string-name>, <string-name>
<surname>Boismenu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wise</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Chevet</surname>
<given-names>E</given-names>
</string-name>
</person-group>. <article-title>Role of pro-oncogenic protein disulfide isomerase (PDI) family member anterior gradient 2 (AGR2) in the control of endoplasmic reticulum homeostasis</article-title>. <source>J Biol Chem</source>
<year>2011</year>;<volume>286</volume>:<fpage>44855</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.275529</pub-id>
<pub-id pub-id-type="pmid">22025610</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Fahy</surname>
<given-names>JV</given-names>
</string-name>, <string-name>
<surname>Dickey</surname>
<given-names>BF</given-names>
</string-name>
</person-group>. <article-title>Airway mucus function and dysfunction</article-title>. <source>N Engl J Med Overseas Ed</source>
<year>2010</year>;<volume>363</volume>:<fpage>2233</fpage>&#x2013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra0910061</pub-id>
</mixed-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Roy</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Livraghi-Butrico</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fletcher</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>McElwee</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Evans</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Boerner</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Alexander</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Bellinghausen</surname>
<given-names>LK</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Petrova</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Tuvim</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Adachi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Romo</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bordt</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Bowden</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Sisson</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Woodruff</surname>
<given-names>PG</given-names>
</string-name>, <string-name>
<surname>Thornton</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Rousseau</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>De la Garza</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Moghaddam</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Karmouty-Quintana</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Blackburn</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Drouin</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Davis</surname>
<given-names>CW</given-names>
</string-name>, <string-name>
<surname>Terrell</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Grubb</surname>
<given-names>BR</given-names>
</string-name>, <string-name>
<surname>O'Neal</surname>
<given-names>WK</given-names>
</string-name>, <string-name>
<surname>Flores</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Cota-Gomez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lozupone</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Donnelly</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Watson</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Hennessy</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Keith</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>IV</given-names>
</string-name>, <string-name>
<surname>Barthel</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Henson</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Janssen</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Schwartz</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Boucher</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Dickey</surname>
<given-names>BF</given-names>
</string-name>, <string-name>
<surname>Evans</surname>
<given-names>CM</given-names>
</string-name>
</person-group>. <article-title>Muc5B is required for airway defence</article-title>. <source>Nature</source>
<year>2014</year>;<volume>505</volume>:<fpage>412</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nature12807</pub-id>
<pub-id pub-id-type="pmid">24317696</pub-id></mixed-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Maldonado-Contreras</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>McCormick</surname>
<given-names>BA</given-names>
</string-name>
</person-group>. <article-title>Intestinal epithelial cells and their role in innate mucosal immunity</article-title>. <source>Cell Tissue Res</source>
<year>2011</year>;<volume>343</volume>:<fpage>5</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-010-1082-5</pub-id>
<pub-id pub-id-type="pmid">21104188</pub-id></mixed-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Miner-Williams</surname>
<given-names>WM</given-names>
</string-name>, <string-name>
<surname>Moughan</surname>
<given-names>PJ</given-names>
</string-name>
</person-group>. <article-title>Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel</article-title>. <source>Nutr Res Rev</source>
<year>2016</year>;<volume>29</volume>:<fpage>40</fpage>&#x2013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1017/S0954422416000019</pub-id>
<pub-id pub-id-type="pmid">27087106</pub-id></mixed-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Velcich</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Heyer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fragale</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nicholas</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Viani</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kucherlapati</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lipkin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Augenlicht</surname>
<given-names>L</given-names>
</string-name>
</person-group>. <article-title>Colorectal cancer in mice genetically deficient in the mucin MUC2</article-title>. <source>Science</source>
<year>2002</year>;<volume>295</volume>:<fpage>1726</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1126/science.1069094</pub-id>
<pub-id pub-id-type="pmid">11872843</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bonser</surname>
<given-names>LR</given-names>
</string-name>, <string-name>
<surname>Schroeder</surname>
<given-names>BW</given-names>
</string-name>, <string-name>
<surname>Ostrin</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Baumlin</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Olson</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Salathe</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Erle</surname>
<given-names>DJ</given-names>
</string-name>
</person-group>. <article-title>The endoplasmic reticulum resident protein AGR3. required for regulation of ciliary beat frequency in the airway</article-title>. <source>Am J Respir Cell Mol Biol</source>
<year>2015</year>;<volume>53</volume>:<fpage>536</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2014-0318OC</pub-id>
<pub-id pub-id-type="pmid">25751668</pub-id></mixed-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Agnel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vermat</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Culouscou</surname>
<given-names>JM</given-names>
</string-name>
</person-group>. <article-title>Identification of three novel members of the calcium-dependent chloride channel (CACC) family predominantly expressed in the digestive tract and trachea</article-title>. <source>FEBS Lett</source>
<year>1999</year>;<volume>455</volume>:<fpage>295</fpage>&#x2013;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(99)00891-1</pub-id>
<pub-id pub-id-type="pmid">10437792</pub-id></mixed-citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Teichgr&#xE4;ber</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Ulrich</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Endlich</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Riethm&#xFC;ller</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wilker</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>De Oliveira-Munding</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>van Heeckeren</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Barr</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>von K&#xFC;rthy</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Schmid</surname>
<given-names>KW</given-names>
</string-name>, <string-name>
<surname>Weller</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>T&#xFC;mmler</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Lang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Grassme</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>D&#xF6;ring</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Gulbins</surname>
<given-names>E</given-names>
</string-name>
</person-group>. <article-title>Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis</article-title>. <source>Nat Med</source>
<year>2008</year>;<volume>14</volume>:<fpage>382</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1038/nm1748</pub-id>
<pub-id pub-id-type="pmid">18376404</pub-id></mixed-citation>
      </ref>
      <ref id="R41">
        <label>41</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ghidoni</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Caretti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Signorelli</surname>
<given-names>P</given-names>
</string-name>
</person-group>. <article-title>Role of sphingolipids in the pathobiology of lung inflammation</article-title>. <source>Mediators Inflamm</source>
<year>2015</year>;<volume>2015</volume>:<fpage>1</fpage>&#x2013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1155/2015/487508</pub-id>
</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>